Pertussis toxin-sensitive heterotrimeric Gαi/o proteins mediate WNT/β-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A

Cellular Signalling

Volumn 25, Issue 4, 2013, Pages 822-828

  Halleskog, Carina ^a   Schulte, Gunnar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Canonical WNT signaling; Frizzled; GPCR; Heterotrimeric G protein; Microglia; Neuroinflammation

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; DICKKOPF 1 PROTEIN; DISHEVELLED PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PERTUSSIS TOXIN; PHOSPHOLIPASE C BETA; PHOSPHOLIPASE C GAMMA; WNT PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINOACETONITRILE; ANIMALS; BETA CATENIN; CALCIUM; CELLS, CULTURED; CYCLOOXYGENASE 2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MICE; MICE, INBRED C57BL; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PERTUSSIS TOXIN; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES; WNT PROTEINS; WNT3A PROTEIN;

EID: 84873290930     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.12.006     Document Type: Article

References (32)

1. Schulte G. Pharmacological Reviews 2010, 62:632-667.
2. Nusse R. Development 2003, 130:5297-5305.
3. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R., Nusse R. Nature 2003, 423:448-452.
4. Shimizu H., Julius M.A., Giarré M., Zheng Z., Brown A.M., Kitajewski J. Cell Growth & Differentiation 1997, 8:1349-1358.
5. MacDonald B.T., Tamai K., He X. Developmental Cell 2009, 17:9-26.
6. Gao C., Chen Y.G. Cellular Signalling 2009, 22:717-727.
7. Schulte G., Bryja V. Trends in Pharmacological Sciences 2007, 28:518-525.
8. Koval A., Purvanov V., Egger-Adam D., Katanaev V.L. Biochemical Pharmacology 2011, 82:1311-1319.
9. Liu T., DeCostanzo A.J., Liu X., Wang H., Hallagan S., Moon R.T., Malbon C.C. Science 2001, 292:1718-1722.
10. Liu X., Rubin J.S., Kimmel A.R. Current Biology 2005, 15:1989-1997.
11. Katanaev V.L., Ponzielli R., Sémériva M., Tomlinson A. Cell 2005, 120:111-122.
12. Hanisch U.K., Kettenmann H. Nature Neuroscience 2007, 10:1387-1394.
13. Halleskog C., Dijksterhuis J.P., Kilander M.B., Becerril-Ortega J., Villaescusa C.J., Lindgren E., Arenas E., Schulte G. Journal of Neuroinflammation 2012, 9.
14. Halleskog C., Mulder J., Dahlström J., Mackie K., Hortobágyi T., Tanila H., Kumar Puli L., Färber K., Harkany T., Schulte G. Glia 2011, 59:119-131.
15. Kilander M., Dijksterhuis J., Ganji R.S., Bryja V., Schulte G. Cellular Signalling 2011, 23:550-554.
16. Kilander M., Halleskog C., Schulte G. Acta Physiologica 2011, 203:363-372.
17. Koistinaho M., Koistinaho J. Glia 2002, 40:175-183.
18. Bikkavilli R.K., Malbon C.C. Communication Integrative Biology 2009, 2:46-49.
19. Wolf J., Mašek J., Krejci P., Wilcox W.R., Kozubík A., Schulte G., Gutkind J.S., Bryja V. Molecular and Cellular Biology 2011, 31:179-189.
20. Krejci P., Aklian A., Kaucka M., Sevcikova E., Prochazkova J., Masek J.K., Mikolka P., Pospisilova T., Spoustova T., Weis M., Paznekas W.A., Wolf J.H., Gutkind J.S., Wilcox W.R., Kozubik A., Jabs E.W., Bryja V., Salazar L., Vesela I., Balek L. PLoS One 2012, 7:e35826.
21. Bryja V., Schulte G., Arenas E. Cellular Signalling 2007, 19:610-616.
22. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Niehrs C. Nature 2001, 411:321-325.
23. Bryja V., Schulte G., Rawal N., Grahn A., Arenas E. Journal of Cell Science 2007, 120:586-595.
24. Cajanek L., Adlerz L., Bryja V., Arenas E. Journal of Cellular Biochemistry 2010, 111:1077-1079.
25. Bonacci T.M., Mathews J.L., Yuan C., Lehmann D.M., Malik S., Wu D., Font J.L., Bidlack J.M., Smrcka A.V. Science 2006, 312:443-446.
26. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Science 1998, 281:1509-1512.
27. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:5522-5527.
28. Pishvaian M.J., Byers S.W. Cancer Biomarkers 2007, 3:263-274.
29. Howe L.R., Subbaramaiah K., Chung W.J., Dannenberg A.J., Brown A.M. Cancer Research 1999, 59:1572-1577.
30. Haertel-Wiesmann M., Liang Y., Fantl W.J., Williams L.T. Journal of Biological Chemistry 2000, 275:32046-32051.
31. Araki Y., Okamura S., Hussain S.P., Nagashima M., He P., Shiseki M., Miura K., Harris C.C. Cancer Research 2003, 63:728-734.
32. Falsig J., van Beek J., Hermann C., Leist M. Journal of Neuroscience Research 2008, 86:1434-1447.